Jize Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Jize Biotechnology - overview
Established
2019
Location
Chongqing, -, China
Primary Industry
Biotechnology
About
Based in Chongqing, China and founded in 2019, Chongqing Jize Biotechnology Co. , Ltd. , trading as Jize Biotechnology, is a pharmaceutical manufacturer with pharmaceutical businesses. In December 2025, Jize Biotechnology raised a series A+ funding from new investors Moutai(Guizhou) Investment Management and Guoli Minsheng Capital.
The company’s business includes pharmaceutical production, wholesale, import and export, retail, food sales, food production, and production of foods for special medical purposes. Through biotechnology, the company develops products for the health and wellness industry and has successfully scaled up its processes for industrialization. The company’s revenue is generated by providing artificial bear bile powder and other pharmaceutical products. The series A+ funds will be used to advance the research and development and production of artificial bear bile powder.
Current Investors
Guoli Minsheng Capital, Moutai(Guizhou) Investment Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Biotechnology, Pharmaceuticals
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.